Alhaddad, A.; Radwan, A.; Mohamed, N.A.; Mehanna, E.T.; Mostafa, Y.M.; El-Sayed, N.M.; Fattah, S.A.
Rosiglitazone Mitigates Dexamethasone-Induced Depression in Mice via Modulating Brain Glucose Metabolism and AMPK/mTOR Signaling Pathway. Biomedicines 2023, 11, 860.
https://doi.org/10.3390/biomedicines11030860
AMA Style
Alhaddad A, Radwan A, Mohamed NA, Mehanna ET, Mostafa YM, El-Sayed NM, Fattah SA.
Rosiglitazone Mitigates Dexamethasone-Induced Depression in Mice via Modulating Brain Glucose Metabolism and AMPK/mTOR Signaling Pathway. Biomedicines. 2023; 11(3):860.
https://doi.org/10.3390/biomedicines11030860
Chicago/Turabian Style
Alhaddad, Aisha, Asmaa Radwan, Noha A. Mohamed, Eman T. Mehanna, Yasser M. Mostafa, Norhan M. El-Sayed, and Shaimaa A. Fattah.
2023. "Rosiglitazone Mitigates Dexamethasone-Induced Depression in Mice via Modulating Brain Glucose Metabolism and AMPK/mTOR Signaling Pathway" Biomedicines 11, no. 3: 860.
https://doi.org/10.3390/biomedicines11030860
APA Style
Alhaddad, A., Radwan, A., Mohamed, N. A., Mehanna, E. T., Mostafa, Y. M., El-Sayed, N. M., & Fattah, S. A.
(2023). Rosiglitazone Mitigates Dexamethasone-Induced Depression in Mice via Modulating Brain Glucose Metabolism and AMPK/mTOR Signaling Pathway. Biomedicines, 11(3), 860.
https://doi.org/10.3390/biomedicines11030860